Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Acurx Pharmaceuticals, Inc. (ACXP) had Weighted-Average Shares Outstanding (Diluted) of 0.81M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-14.10M |
|
-- |
|
-- |
|
$14.10M |
|
$-14.10M |
|
-- |
|
$-14.10M |
|
$-14.10M |
|
$-14.10M |
|
$-14.10M |
|
$-14.10M |
|
$-14.10M |
|
$-14.10M |
|
$-14.10M |
|
0.81M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.81M |
$-17.40 |
|
$-17.40 |
|
| Balance Sheet Financials | |
$3.86M |
|
-- |
|
-- |
|
$3.86M |
|
$3.24M |
|
-- |
|
-- |
|
$3.24M |
|
$0.62M |
|
$0.62M |
|
$0.62M |
|
0.85M |
|
| Cash Flow Statement Financials | |
$-10.38M |
|
-- |
|
$6.62M |
|
$7.47M |
|
$3.71M |
|
$-3.77M |
|
$3.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2292.74% |
|
-2292.74% |
|
-365.56% |
|
-2292.74% |
|
$0.72 |
|
$-12.85 |
|
$-12.85 |
|